foxo4-dri senolytic or senomorphic (Proxofim) 10mg*10 vials - Nexus peptides The FOXO4 peptide in a
The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Targeting cellular senescence with senotherapeutics: senolytics and senomorphics Zhang 2023 The FEBS Journal Wiley Online Library Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Results: What to Expect (2026)
Pay in 4 interest-free payments of $7.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




